694

500087

CIPLA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

CIPLA LTD Share Price Today

CIPLA LTD is currently trading at ₹1440.1, up by ₹2.19 from the previous close. The stock touched an intraday high of ₹1453.00 and a low of ₹1431.00 during the latest trading session. Over the past one year, CIPLA LTD has delivered a loss of 4.62%, while the stock has gained 1.85% in the last one month.

CIPLA LTD performance

Today’s low Today’s high
₹ 1431.00 ₹ 1453.00
₹ 1440.10
52 week low 52 week high
₹ 1165.70 ₹ 1673.00
₹ 1440.10
Open Price ₹ 1448.00
Prev. Close ₹ 1437.90
Volume (Shares) 1217683.00
Total traded value ₹ 17535.85
Upper Circuit ₹ 1581.60
Lower Circuit ₹ 1294.20
info

Investment Returns

Over 1 Month 1.85% Over 3 Months 15.72% Over 6 Months -4.37% Over 1 Year -4.62%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

CIPLA LTD fundamentals


  • Market cap (Cr) 1,16,337.80
  • P/E Ratio (TTM) 33.10
  • Beta 0.58
  • Book Value / share 423.36
  • Return on equity 10.60%
  • EPS (TTM) 42.61
  • Dividend yield 0.90%
  • Net profit/quarter (Cr) 384.64
info icon alternate text
  • Market cap (Cr) 1,16,354.00
  • P/E Ratio (TTM) 33.10
  • Beta 0.48
  • Book Value / share 423.36
  • Return on equity 10.60%
  • EPS (TTM) 42.61
  • Dividend yield 0.90%
  • Net profit/quarter (Cr) 384.64
info icon alternate text

CIPLA LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 3840.92
Operating Expense 3867.72
Net Profit 384.64
Net Profit Margin (%) 10.01
Earnings Per Share (EPS) 4.76
EBITDA 747.33
Effective Tax Rate (%) 26.38
Particulars DEC 2025 (Values in Cr)
Revenue 4256.93
Operating Expense 3934.24
Net Profit 616.88
Net Profit Margin (%) 14.49
Earnings Per Share (EPS) 7.64
EBITDA 893.53
Effective Tax Rate (%) 16.20
Particulars SEP 2025 (Values in Cr)
Revenue 4495.16
Operating Expense 3847.04
Net Profit 1210.53
Net Profit Margin (%) 26.92
Earnings Per Share (EPS) 14.99
EBITDA 1777.29
Effective Tax Rate (%) 25.88
Particulars JUN 2025 (Values in Cr)
Revenue 4501.66
Operating Expense 3573.29
Net Profit 1303.13
Net Profit Margin (%) 28.94
Earnings Per Share (EPS) 16.13
EBITDA 1895.52
Effective Tax Rate (%) 25.27
Particulars MAR 2025 (Values in Cr)
Revenue 4254.47
Operating Expense 3630.37
Net Profit 1485.40
Net Profit Margin (%) 34.91
Earnings Per Share (EPS) 18.39
EBITDA 1906.74
Effective Tax Rate (%) 15.38
Particulars MAR 2026 (Values in Cr)
Revenue 17094.67
Operating Expense 15222.28
Net Profit 3515.18
Net Profit Margin (%) 20.56
Earnings Per Share (EPS) 43.52
EBITDA 5313.67
Effective Tax Rate (%) 24.17
Particulars MAR 2025 (Values in Cr)
Revenue 16111.45
Operating Expense 13855.41
Net Profit 5157.65
Net Profit Margin (%) 32.01
Earnings Per Share (EPS) 63.87
EBITDA 7057.82
Effective Tax Rate (%) 20.26
Particulars MAR 2024 (Values in Cr)
Revenue 14441.14
Operating Expense 12698.03
Net Profit 4077.25
Net Profit Margin (%) 28.23
Earnings Per Share (EPS) 50.51
EBITDA 5554.81
Effective Tax Rate (%) 24.91
Particulars MAR 2023 (Values in Cr)
Revenue 13073.53
Operating Expense 11610.63
Net Profit 2513.47
Net Profit Margin (%) 19.22
Earnings Per Share (EPS) 31.15
EBITDA 3623.77
Effective Tax Rate (%) 28.66
Particulars MAR 2022 (Values in Cr)
Revenue 15052.48
Operating Expense 12243.14
Net Profit 2957.93
Net Profit Margin (%) 19.65
Earnings Per Share (EPS) 36.67
EBITDA 4377.93
Effective Tax Rate (%) 24.22
Particulars MAR 2026 (Values in Cr)
Book Value / Share 426.24
ROE % 11.79
ROCE % 15.66
Total Debt to Total Equity 0.02
EBITDA Margin 16.63
Particulars MAR 2025 (Values in Cr)
Book Value / Share 386.25
ROE % 18.28
ROCE % 23.15
Total Debt to Total Equity 0.02
EBITDA Margin 21.57
Particulars MAR 2024 (Values in Cr)
Book Value / Share 330.79
ROE % 16.58
ROCE % 22.27
Total Debt to Total Equity 0.03
EBITDA Margin 26.55
Particulars MAR 2023 (Values in Cr)
Book Value / Share 290.01
ROE % 12.82
ROCE % 17.79
Total Debt to Total Equity 0.04
EBITDA Margin 23.38
Particulars MAR 2022 (Values in Cr)
Book Value / Share 258.33
ROE % 13.07
ROCE % 16.83
Total Debt to Total Equity 0.08
EBITDA Margin 21.37
Particulars MAR 2026 (Values in Cr)
Book Value / Share 423.39
ROE % 10.60
ROCE % 13.88
Total Debt to Total Equity 0.00
EBITDA Margin 26.48
Particulars MAR 2025 (Values in Cr)
Book Value / Share 397.46
ROE % 17.17
ROCE % 21.40
Total Debt to Total Equity 0.00
EBITDA Margin 35.37
Particulars MAR 2024 (Values in Cr)
Book Value / Share 346.49
ROE % 15.50
ROCE % 20.10
Total Debt to Total Equity 0.00
EBITDA Margin 35.71
Particulars MAR 2023 (Values in Cr)
Book Value / Share 305.25
ROE % 10.66
ROCE % 14.28
Total Debt to Total Equity 0.00
EBITDA Margin 27.84
Particulars MAR 2022 (Values in Cr)
Book Value / Share 279.05
ROE % 13.94
ROCE % 18.21
Total Debt to Total Equity 0.00
EBITDA Margin 28.95
Particulars MAR 2026 (Values in Cr)
Cash & Short Term Investments 1307.42
Total Assets 42495.98
Total Liabilities 42495.98
Total Equity 34520.24
Share Outstanding 80
Price to Book Ratio 2.89
Return on Assets (%) 9.12
Return on Capital (%) 11.15
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 799.84
Total Assets 37387.04
Total Liabilities 37387.04
Total Equity 31289.25
Share Outstanding 80
Price to Book Ratio 3.63
Return on Assets (%) 14.10
Return on Capital (%) 16.8
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 874.97
Total Assets 32717.82
Total Liabilities 32717.82
Total Equity 26802.33
Share Outstanding 80
Price to Book Ratio 4.31
Return on Assets (%) 12.59
Return on Capital (%) 15.24
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1564.62
Total Assets 29463.28
Total Liabilities 29463.28
Total Equity 23713.54
Share Outstanding 80
Price to Book Ratio 2.95
Return on Assets (%) 9.50
Return on Capital (%) 11.56
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1928.48
Total Assets 27101.12
Total Liabilities 27101.12
Total Equity 21117.38
Share Outstanding 80
Price to Book Ratio 3.65
Return on Assets (%) 9.28
Return on Capital (%) 11.47
Particulars MAR 2026 (Values in Cr)
Cash & Short Term Investments 518.60
Total Assets 38493.09
Total Liabilities 38493.09
Total Equity 34201.11
Share Outstanding 80
Price to Book Ratio 2.89
Return on Assets (%) 9.13
Return on Capital (%) 10.27
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 278.45
Total Assets 35565.72
Total Liabilities 35565.72
Total Equity 32099.24
Share Outstanding 80
Price to Book Ratio 3.63
Return on Assets (%) 14.50
Return on Capital (%) 16.07
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 333.20
Total Assets 31053.23
Total Liabilities 31053.23
Total Equity 27973.92
Share Outstanding 80
Price to Book Ratio 4.31
Return on Assets (%) 13.12
Return on Capital (%) 14.58
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 966.46
Total Assets 27596.47
Total Liabilities 27596.47
Total Equity 24638.09
Share Outstanding 80
Price to Book Ratio 2.95
Return on Assets (%) 9.10
Return on Capital (%) 10.2
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1428.03
Total Assets 25449.05
Total Liabilities 25449.05
Total Equity 22513.55
Share Outstanding 80
Price to Book Ratio 3.65
Return on Assets (%) 11.62
Return on Capital (%) 13.14
Particulars MAR 2026 (Values in Cr)
Net Income 5223.63
Cash from Operations 5526.22
Cash from Investing -2326.13
Cash from Financing -1233.65
Net change in Cash 380.24
Free Cash Flow 7125.55
Particulars MAR 2025 (Values in Cr)
Net Income 6820.81
Cash from Operations 6673.08
Cash from Investing -3691.14
Cash from Financing -1292.79
Net change in Cash 21.05
Free Cash Flow 7835.24
Particulars MAR 2024 (Values in Cr)
Net Income 5896.72
Cash from Operations 5731.39
Cash from Investing -2988.03
Cash from Financing -1200.43
Net change in Cash -54.55
Free Cash Flow 6829.64
Particulars MAR 2023 (Values in Cr)
Net Income 4220.77
Cash from Operations 4539.54
Cash from Investing -2388.51
Cash from Financing -958.29
Net change in Cash -109.15
Free Cash Flow 5380.07
Particulars MAR 2022 (Values in Cr)
Net Income 3675.39
Cash from Operations 4465.40
Cash from Investing -1871.88
Cash from Financing -1599.79
Net change in Cash -145.77
Free Cash Flow 5009.50
Particulars MAR 2026 (Values in Cr)
Net Income 4635.94
Cash from Operations 4054.10
Cash from Investing -1344.09
Cash from Financing -1321.90
Net change in Cash 165.70
Free Cash Flow 4834.79
Particulars MAR 2025 (Values in Cr)
Net Income 6468.82
Cash from Operations 4659.35
Cash from Investing -2308.53
Cash from Financing -1073.93
Net change in Cash -81.47
Free Cash Flow 5230.41
Particulars MAR 2024 (Values in Cr)
Net Income 5432.14
Cash from Operations 4950.93
Cash from Investing -2882.82
Cash from Financing -708.83
Net change in Cash 135.12
Free Cash Flow 5501.42
Particulars MAR 2023 (Values in Cr)
Net Income 3685.17
Cash from Operations 4119.31
Cash from Investing -2757.95
Cash from Financing -424.77
Net change in Cash -147.67
Free Cash Flow 4705.71
Particulars MAR 2022 (Values in Cr)
Net Income 3905.08
Cash from Operations 3707.46
Cash from Investing -2463.73
Cash from Financing -426.72
Net change in Cash -117.02
Free Cash Flow 4012.50
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 31.51 13.02 1.52 241.47 23.12 38.85
BLISS GVS PHARMA LTD. 492.50 39.98 4.37 5223.27 118.35 495.00
FERMENTA BIOTECH LTD. 365.50 16.12 2.64 1075.70 256.40 399.00
GLAXOSMITHKLINE PHARMACEUTICAL 2358.85 41.53 17.62 39960.34 2088.00 3500.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 31.51 22.03 4.05 241.47 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 538.05 24.12 4.20 1555.54 490.00 789.95
ASTRAZENECA PHARMA IND LT 8382.65 109.48 24.01 20956.63 7630.00 9850.00
BLISS GVS PHARMA LTD. 492.50 53.13 4.52 5223.27 118.35 495.00

CIPLA LTD shareholding pattern

Holding
16.25%
29.21%
22.55%
31.96%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

CIPLA LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1440.10 0.15 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 1420.20
  • 26 Days 1387.10
  • 10 Days 1405.00
  • 50 Days 1367.80
  • 12 Days 1401.80
  • 100 Days 1365.90
  • 20 Days 1393.10
  • 200 Days 1398.70
1438.50 PIVOT
First Support 1425.10 First Resistance 1451.30 Second Support 1412.30 Second Resistance 1464.70 Third Support 1398.90 Third Resistance 1477.50
RSI 65.46 ADX 34.85 MACD 14.70 Williams % R -17.43 Commodity Channel Index (CCI) 183.46
Date 2026-06-25 Week 1074066.00 Same Day 698125.00 Month 1054190.00
1 Year 0.59 3 Year 0.52
Over 1 Month
1.85% down
Over 1 Year
-4.62% down
Over 3 Months
15.72% down
Over 3 Years
12.11% down
Over 6 Months
-4.37% down
Over 5 Years
8.51% down

CIPLA LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
05 Jun 2026 13.0 Final 05 Jun 2026 Equity shares
27 Jun 2025 3.0 Special 27 Jun 2025 Equity shares
27 Jun 2025 13.0 Final 27 Jun 2025 Equity shares
02 Aug 2024 13.0 Final 02 Aug 2024 Equity shares
21 Jul 2023 8.5 Final 21 Jul 2023 Equity shares
08 Aug 2022 5.0 Final 10 Aug 2022 Equity shares
09 Aug 2021 5.0 Final 11 Aug 2021 Equity shares
19 Mar 2020 1.0 Special 20 Mar 2020 Equity shares
19 Mar 2020 3.0 Interim 20 Mar 2020 Equity shares
31 Jul 2019 3.0 Final 02 Aug 2019 Equity shares
13 Aug 2018 3.0 Final 16 Aug 2018 Equity shares
26 Jul 2017 2.0 Final 28 Jul 2017 Equity shares
12 Sep 2016 2.0 Final 15 Sep 2016 Equity shares
11 Aug 2015 2.0 Final 13 Aug 2015 Equity shares
06 Aug 2014 2.0 Final 08 Aug 2014 Equity shares
06 Aug 2013 2.0 Final 08 Aug 2013 Equity shares
01 Aug 2012 2.0 Final 03 Aug 2012 Equity shares
09 Aug 2011 2.0 Final 11 Aug 2011 Equity shares
03 Sep 2010 0.8 Interim 06 Sep 2010 Equity shares
23 Jul 2010 2.0 Final 27 Jul 2010 Equity shares
10 Aug 2009 2.0 Final 12 Aug 2009 Equity shares
12 Aug 2008 2.0 Final 14 Aug 2008 Equity shares
08 Aug 2007 2.0 Final 10 Aug 2007 Equity shares
18 Aug 2006 0.0 Final 22 Aug 2006 Equity shares
19 Aug 2005 0.0 Final 23 Aug 2005 Equity shares
Ex-Date Ex-Bonus Ratio
25 Apr 2006 24 Apr 2006 3:2
05 Nov 1999 18 Oct 1999 2:1
Ex-Date Old FV NEW FV Record Date
11 May 2004 10.0 2.0 19 May 2004
Dividend date Dividend amount Dividend type Record date Instrument type
05 Jun 2026 13.0 Final 05 Jun 2026 Equity shares
27 Jun 2025 3.0 Special 27 Jun 2025 Equity shares
27 Jun 2025 13.0 Final 27 Jun 2025 Equity shares
02 Aug 2024 13.0 Final 02 Aug 2024 Equity shares
21 Jul 2023 8.5 Final 21 Jul 2023 Equity shares
08 Aug 2022 5.0 Final 10 Aug 2022 Equity shares
09 Aug 2021 5.0 Final 11 Aug 2021 Equity shares
19 Mar 2020 1.0 Special 20 Mar 2020 Equity shares
19 Mar 2020 3.0 Interim 20 Mar 2020 Equity shares
31 Jul 2019 3.0 Final 02 Aug 2019 Equity shares
13 Aug 2018 3.0 Final 16 Aug 2018 Equity shares
26 Jul 2017 2.0 Final 28 Jul 2017 Equity shares
12 Sep 2016 2.0 Final 15 Sep 2016 Equity shares
11 Aug 2015 2.0 Final 13 Aug 2015 Equity shares
06 Aug 2014 2.0 Final 08 Aug 2014 Equity shares
06 Aug 2013 2.0 Final 08 Aug 2013 Equity shares
01 Aug 2012 2.0 Final 03 Aug 2012 Equity shares
09 Aug 2011 2.0 Final 11 Aug 2011 Equity shares
03 Sep 2010 0.8 Interim 06 Sep 2010 Equity shares
23 Jul 2010 2.0 Final 27 Jul 2010 Equity shares
10 Aug 2009 2.0 Final 12 Aug 2009 Equity shares
12 Aug 2008 2.0 Final 14 Aug 2008 Equity shares
08 Aug 2007 2.0 Final 10 Aug 2007 Equity shares
18 Aug 2006 0.0 Final 22 Aug 2006 Equity shares
19 Aug 2005 0.0 Final 23 Aug 2005 Equity shares
Ex-Date Ex-Bonus Ratio
25 Apr 2006 24 Apr 2006 3:2
05 Nov 1999 18 Oct 1999 2:1
Ex-Date Old FV NEW FV Record Date
11 May 2004 10.0 2.0 19 May 2004

Top Gainers

Top Losers

About the Company

Cipla Limited was founded by Dr. Khwaja Abdul Hamied in 1935, then named Chemical Industrial and Pharmaceutical Laboratories Ltd. in Mumbai. Dr. Hamied had studied chemistry in Berlin and returned to India with the intent of building a domestic pharmaceutical industry. The company's name was shortened to Cipla Limited in 1984. The company is headquartered in Mumbai, Maharashtra. Cipla Limited is listed on the National Stock Exchange under the ticker CIPLA and on BSE under the security code 500087, and is a constituent of the NSE Nifty 50.

Dr. Hamied's son, Dr. Y. K. Hamied, took over and steered the company through several decades of growth. In 2001, Cipla offered a triple anti-retroviral HIV/AIDS therapy in Africa at under a dollar a day, a move that drew wide international attention. As of May 2026, The company markets a broad portfolio of pharmaceutical products across multiple therapeutic area across therapeutic areas — respiratory, cardiovascular, oncology, anti-infective, and others —across international markets , supported by a global manufacturing network facilities. Its US subsidiary, InvaGen Pharmaceuticals, supports its North America operations.

Cipla Ltd. is a constituent of Nifty 50, Nifty 100, Nifty 200, Nifty 500, Nifty Pharma and Nifty Healthcare.

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Cipla Ltd?

Answer Field

Cipla Ltd share price is for NSE ₹ 1,440.10 & for BSE ₹ 1,439.95 as on Jun 25 2026 03:30 PM.

What is the Market Cap of Cipla Ltd Share?

Answer Field

The market cap of Cipla Ltd for NSE ₹ 0.01 & for BSE ₹ 0.01 as on Jun 25 2026 03:30 PM.

What is the 52 Week High and Low of Cipla Ltd?

Answer Field

The 52 Week High and Low of Cipla Ltd for NSE is ₹ 1,673.00 and ₹ 1,165.70 and for BSE is ₹ 1,672.20 and ₹ 1,165.55.

What is 1 year return for Cipla Ltd?

Answer Field

The 1 year returns on the stock has been -4.62%.

What is the P/E Ratio of Cipla Ltd Share?

Answer Field

As on Jun 25 2026 03:30 PM the price-to-earnings (PE) ratio for Cipla Ltd share is 33.10.

What is the PB ratio of Cipla Ltd Share?

Answer Field

As on Jun 25 2026 03:30 PM, the price-to-book (PB) ratio for Cipla Ltd share is 423.36.

How to Buy Cipla Ltd Share?

Answer Field

You can trade in Cipla Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Cipla Ltd Share on Bajaj Broking App?

Answer Field

To buy Cipla Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Cipla Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

Who is the CEO of Cipla Ltd?

Answer Field

The CEO of Cipla Ltd is Umang Vohra, who has held the position of Managing Director and Global Chief Executive Officer (MD and GCEO) since September 2016. His leadership is instrumental in driving Cipla’s strategic growth in the pharmaceutical sector.

When was Cipla Ltd established?

Answer Field

Cipla Ltd was established in 1935, marking its presence in the pharmaceutical industry for nearly a century. Its foundation has enabled it to become a respected and influential player with a long-standing history.

What factors influence the Cipla Share Price?

Answer Field

The Cipla share price is influenced by several factors, including quarterly earnings, overall sector performance, regulatory changes, and economic conditions. Investor sentiment, competitive landscape, and global healthcare trends also play a significant role.

Is Cipla Ltd debt free?

Answer Field

Cipla Ltd is not entirely debt-free; the company manages a balanced financial structure that includes both debt and equity. This approach enables Cipla to fund growth initiatives while maintaining financial flexibility in a competitive market.

What is the CAGR of Cipla Share?

Answer Field

The CAGR for Cipla shares varies by timeframe: over the past 10 years, it stands at 9%, over 5 years at 28%, over 3 years at 20%, and in the past year at 27%, reflecting robust growth in recent periods.

How has the Cipla Share Price performed over the past year?

Answer Field

The Cipla share price has shown strong performance, with a 1-year CAGR of 27%. This growth reflects Cipla’s operational achievements and investor confidence, showcasing the stock's resilience and value appreciation over the last year.

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|